We are live on ! Find out more
NMRD

Nemaura Medical, Inc. Common Stock

Delisted

NMRD was delisted on the 4th of January, 2024.

6 hedge funds and large institutions have $133K invested in Nemaura Medical, Inc. Common Stock in 2018 Q3 according to their latest regulatory filings, with 4 funds opening new positions, increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more funds holding

Funds holding: 26 (+4)

37% more capital invested

Capital invested by funds: $97K → $133K (+$36K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
6
Holders Change
+4
Holders Change %
+200%
% of All Funds
0.14%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
Reduced
1
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
PGCM
1
Prescott Group Capital Management
Oklahoma
$44K +$45.9K +1,850 New
SC
2
Scotia Capital
Ontario, Canada
$30K
Citadel Advisors
3
Citadel Advisors
Florida
$27K -$6.93K -279 -20%
VF
4
Virtu Financial
New York
$24K +$25.5K +1,026 New
UBS Group
5
UBS Group
Switzerland
$7K +$7K +282 New
Deutsche Bank
6
Deutsche Bank
Germany
$1K +$745 +30 New

NMRD Hedge Fund Activity: Q3 2018 in Review

6 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Nemaura Medical, Inc. Common Stock (NMRD) for Q3 2018, worth a combined $133K — up 37% from $97K a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new NMRD positions and 0 closed out — a net gain of 4 holders — while 0 added to existing stakes and 1 trimmed.

The largest buyer was Prescott Group Capital Management, opening a new position worth an estimated $45.9K. The largest seller was Citadel Advisors, cutting an estimated $6.93K.

  • 6 institutional investors held Nemaura Medical, Inc. Common Stock (NMRD) as of Q3 2018, up from 2 in Q2 2018.
  • Funds reported $133K of Nemaura Medical, Inc. Common Stock stock for Q3 2018, up 37% quarter-over-quarter.
  • 4 funds opened new Nemaura Medical, Inc. Common Stock positions in Q3 2018 and 0 closed out, a net change of +4 holders.
  • The largest Nemaura Medical, Inc. Common Stock buyer in Q3 2018 was Prescott Group Capital Management, an estimated $45.9K added.
  • The largest Nemaura Medical, Inc. Common Stock seller in Q3 2018 was Citadel Advisors, an estimated $6.93K sold.

Based on aggregated 13F filings for Q3 2018.